BindingDB logo
myBDB logout

Patent code US8987313

Compile Data Set for Download or QSAR
Found 34 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151195
PNG
(US8987313, 36)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)NC(C)=O)cs1 |r|
Show InChI InChI=1S/C39H49N7O5S2/c1-26(2)37-43-33(24-52-37)21-45(4)39(50)46-22-32(41-27(3)47)19-35(46)36(48)42-30(17-28-11-7-5-8-12-28)15-16-31(18-29-13-9-6-10-14-29)44-38(49)51-23-34-20-40-25-53-34/h5-14,20,24-26,30-32,35H,15-19,21-23H2,1-4H3,(H,41,47)(H,42,48)(H,44,49)/t30-,31-,32+,35+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a<100n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151194
PNG
(US8987313, 35)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@H](CC[C@@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)N2CCOCC2)cs1 |r|
Show InChI InChI=1S/C41H53N7O5S2/c1-29(2)39-44-34(27-54-39)24-46(3)41(51)48-25-35(47-16-18-52-19-17-47)22-37(48)38(49)43-32(20-30-10-6-4-7-11-30)14-15-33(21-31-12-8-5-9-13-31)45-40(50)53-26-36-23-42-28-55-36/h4-13,23,27-29,32-33,35,37H,14-22,24-26H2,1-3H3,(H,43,49)(H,45,50)/t32-,33-,35+,37-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a<100n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151197
PNG
(US8987313, 42)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CCC[C@@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O4S2/c1-26(2)35-40-31(24-48-35)22-42(3)37(46)43-18-10-15-33(43)34(44)39-29(19-27-11-6-4-7-12-27)16-17-30(20-28-13-8-5-9-14-28)41-36(45)47-23-32-21-38-25-49-32/h4-9,11-14,21,24-26,29-30,33H,10,15-20,22-23H2,1-3H3,(H,39,44)(H,41,45)/t29-,30-,33-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 110n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151193
PNG
(US8987313, 32)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)N2CCOCC2)cs1 |r|
Show InChI InChI=1S/C41H53N7O5S2/c1-29(2)39-44-34(27-54-39)24-46(3)41(51)48-25-35(47-16-18-52-19-17-47)22-37(48)38(49)43-32(20-30-10-6-4-7-11-30)14-15-33(21-31-12-8-5-9-13-31)45-40(50)53-26-36-23-42-28-55-36/h4-13,23,27-29,32-33,35,37H,14-22,24-26H2,1-3H3,(H,43,49)(H,45,50)/t32-,33-,35+,37+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 120n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151187
PNG
(US8987313, 11)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC[C@@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O5S2/c1-25(2)35-40-30(23-49-35)20-42(3)37(47)43-21-31(44)18-33(43)34(45)39-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)41-36(46)48-22-32-19-38-24-50-32/h4-13,19,23-25,28-29,31,33,44H,14-18,20-22H2,1-3H3,(H,39,45)(H,41,46)/t28-,29-,31+,33-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 120n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151196
PNG
(US8987313, 39)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CCC[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O4S2/c1-26(2)35-40-31(24-48-35)22-42(3)37(46)43-18-10-15-33(43)34(44)39-29(19-27-11-6-4-7-12-27)16-17-30(20-28-13-8-5-9-14-28)41-36(45)47-23-32-21-38-25-49-32/h4-9,11-14,21,24-26,29-30,33H,10,15-20,22-23H2,1-3H3,(H,39,44)(H,41,45)/t29-,30-,33+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 130n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151191
PNG
(US8987313, 25)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CCN(C)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C38H49N7O4S2/c1-27(2)36-41-32(25-50-36)22-44(4)38(48)45-18-17-43(3)23-34(45)35(46)40-30(19-28-11-7-5-8-12-28)15-16-31(20-29-13-9-6-10-14-29)42-37(47)49-24-33-21-39-26-51-33/h5-14,21,25-27,30-31,34H,15-20,22-24H2,1-4H3,(H,40,46)(H,42,47)/t30-,31-,34+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 140n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151201
PNG
(US8987313, 31)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)N(C)C)cs1 |r|
Show InChI InChI=1S/C39H51N7O4S2/c1-27(2)37-42-32(25-51-37)22-45(5)39(49)46-23-33(44(3)4)20-35(46)36(47)41-30(18-28-12-8-6-9-13-28)16-17-31(19-29-14-10-7-11-15-29)43-38(48)50-24-34-21-40-26-52-34/h6-15,21,25-27,30-31,33,35H,16-20,22-24H2,1-5H3,(H,41,47)(H,43,48)/t30-,31-,33+,35+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 150n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151199
PNG
(US8987313, 24)
Show SMILES CC(C)c1nc(CN(C)C(=O)NC2(CCNCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C38H49N7O4S2/c1-27(2)34-41-32(25-50-34)23-45(3)36(47)44-38(16-18-39-19-17-38)35(46)42-30(20-28-10-6-4-7-11-28)14-15-31(21-29-12-8-5-9-13-29)43-37(48)49-24-33-22-40-26-51-33/h4-13,22,25-27,30-31,39H,14-21,23-24H2,1-3H3,(H,42,46)(H,43,48)(H,44,47)/t30-,31-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 150n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151194
PNG
(US8987313, 35)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@H](CC[C@@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)N2CCOCC2)cs1 |r|
Show InChI InChI=1S/C41H53N7O5S2/c1-29(2)39-44-34(27-54-39)24-46(3)41(51)48-25-35(47-16-18-52-19-17-47)22-37(48)38(49)43-32(20-30-10-6-4-7-11-30)14-15-33(21-31-12-8-5-9-13-31)45-40(50)53-26-36-23-42-28-55-36/h4-13,23,27-29,32-33,35,37H,14-22,24-26H2,1-3H3,(H,43,49)(H,45,50)/t32-,33-,35+,37-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 150n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151189
PNG
(US8987313, 18)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CS(=O)(=O)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C36H44N6O6S3/c1-25(2)34-39-30(21-49-34)19-41(3)36(45)42-24-51(46,47)22-32(42)33(43)38-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)40-35(44)48-20-31-18-37-23-50-31/h4-13,18,21,23,25,28-29,32H,14-17,19-20,22,24H2,1-3H3,(H,38,43)(H,40,44)/t28-,29-,32+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 160n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151185
PNG
(US8987313, 5)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O5S2/c1-25(2)35-40-30(23-49-35)20-42(3)37(47)43-21-31(44)18-33(43)34(45)39-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)41-36(46)48-22-32-19-38-24-50-32/h4-13,19,23-25,28-29,31,33,44H,14-18,20-22H2,1-3H3,(H,39,45)(H,41,46)/t28-,29-,31-,33+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 160n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151186
PNG
(US8987313, 8)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@@H](O)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O5S2/c1-25(2)35-40-30(23-49-35)20-42(3)37(47)43-21-31(44)18-33(43)34(45)39-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)41-36(46)48-22-32-19-38-24-50-32/h4-13,19,23-25,28-29,31,33,44H,14-18,20-22H2,1-3H3,(H,39,45)(H,41,46)/t28-,29-,31+,33+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 170n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151200
PNG
(US8987313, 30)
Show SMILES CN[C@H]1C[C@H](N(C1)C(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](CC[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1 |r|
Show InChI InChI=1S/C38H49N7O4S2/c1-26(2)36-42-32(24-50-36)21-44(4)38(48)45-22-31(39-3)19-34(45)35(46)41-29(17-27-11-7-5-8-12-27)15-16-30(18-28-13-9-6-10-14-28)43-37(47)49-23-33-20-40-25-51-33/h5-14,20,24-26,29-31,34,39H,15-19,21-23H2,1-4H3,(H,41,46)(H,43,47)/t29-,30-,31+,34+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 170n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151198
PNG
(US8987313, 49)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2Cc3nc[nH]c3C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 190n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151190
PNG
(US8987313, 21)
Show SMILES CC(C)c1nc(CN(C)C(=O)NC2(CCN(C)CC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C39H51N7O4S2/c1-28(2)35-41-33(26-51-35)24-46(4)37(48)44-39(17-19-45(3)20-18-39)36(47)42-31(21-29-11-7-5-8-12-29)15-16-32(22-30-13-9-6-10-14-30)43-38(49)50-25-34-23-40-27-52-34/h5-14,23,26-28,31-32H,15-22,24-25H2,1-4H3,(H,42,47)(H,43,49)(H,44,48)/t31-,32-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 190n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151192
PNG
(US8987313, 29)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@@H](N)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H47N7O4S2/c1-25(2)35-41-31(23-49-35)21-43(3)37(47)44-20-28(38)18-33(44)34(45)40-29(16-26-10-6-4-7-11-26)14-15-30(17-27-12-8-5-9-13-27)42-36(46)48-22-32-19-39-24-50-32/h4-13,19,23-25,28-30,33H,14-18,20-22,38H2,1-3H3,(H,40,45)(H,42,46)/t28-,29+,30+,33-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 190n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151188
PNG
(US8987313, 16)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CSC[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C36H44N6O4S3/c1-25(2)34-39-30(21-48-34)19-41(3)36(45)42-24-47-22-32(42)33(43)38-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)40-35(44)46-20-31-18-37-23-49-31/h4-13,18,21,23,25,28-29,32H,14-17,19-20,22,24H2,1-3H3,(H,38,43)(H,40,44)/t28-,29-,32+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 200n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151185
PNG
(US8987313, 5)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O5S2/c1-25(2)35-40-30(23-49-35)20-42(3)37(47)43-21-31(44)18-33(43)34(45)39-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)41-36(46)48-22-32-19-38-24-50-32/h4-13,19,23-25,28-29,31,33,44H,14-18,20-22H2,1-3H3,(H,39,45)(H,41,46)/t28-,29-,31-,33+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 230n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151186
PNG
(US8987313, 8)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@@H](O)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O5S2/c1-25(2)35-40-30(23-49-35)20-42(3)37(47)43-21-31(44)18-33(43)34(45)39-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)41-36(46)48-22-32-19-38-24-50-32/h4-13,19,23-25,28-29,31,33,44H,14-18,20-22H2,1-3H3,(H,39,45)(H,41,46)/t28-,29-,31+,33+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 240n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151197
PNG
(US8987313, 42)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CCC[C@@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O4S2/c1-26(2)35-40-31(24-48-35)22-42(3)37(46)43-18-10-15-33(43)34(44)39-29(19-27-11-6-4-7-12-27)16-17-30(20-28-13-8-5-9-14-28)41-36(45)47-23-32-21-38-25-49-32/h4-9,11-14,21,24-26,29-30,33H,10,15-20,22-23H2,1-3H3,(H,39,44)(H,41,45)/t29-,30-,33-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 250n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151196
PNG
(US8987313, 39)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CCC[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O4S2/c1-26(2)35-40-31(24-48-35)22-42(3)37(46)43-18-10-15-33(43)34(44)39-29(19-27-11-6-4-7-12-27)16-17-30(20-28-13-8-5-9-14-28)41-36(45)47-23-32-21-38-25-49-32/h4-9,11-14,21,24-26,29-30,33H,10,15-20,22-23H2,1-3H3,(H,39,44)(H,41,45)/t29-,30-,33+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 260n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151189
PNG
(US8987313, 18)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CS(=O)(=O)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C36H44N6O6S3/c1-25(2)34-39-30(21-49-34)19-41(3)36(45)42-24-51(46,47)22-32(42)33(43)38-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)40-35(44)48-20-31-18-37-23-50-31/h4-13,18,21,23,25,28-29,32H,14-17,19-20,22,24H2,1-3H3,(H,38,43)(H,40,44)/t28-,29-,32+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 260n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151188
PNG
(US8987313, 16)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CSC[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C36H44N6O4S3/c1-25(2)34-39-30(21-48-34)19-41(3)36(45)42-24-47-22-32(42)33(43)38-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)40-35(44)46-20-31-18-37-23-49-31/h4-13,18,21,23,25,28-29,32H,14-17,19-20,22,24H2,1-3H3,(H,38,43)(H,40,44)/t28-,29-,32+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 300n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151191
PNG
(US8987313, 25)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2CCN(C)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C38H49N7O4S2/c1-27(2)36-41-32(25-50-36)22-44(4)38(48)45-18-17-43(3)23-34(45)35(46)40-30(19-28-11-7-5-8-12-28)15-16-31(20-29-13-9-6-10-14-29)42-37(47)49-24-33-21-39-26-51-33/h5-14,21,25-27,30-31,34H,15-20,22-24H2,1-4H3,(H,40,46)(H,42,47)/t30-,31-,34+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 300n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151187
PNG
(US8987313, 11)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC[C@@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H46N6O5S2/c1-25(2)35-40-30(23-49-35)20-42(3)37(47)43-21-31(44)18-33(43)34(45)39-28(16-26-10-6-4-7-11-26)14-15-29(17-27-12-8-5-9-13-27)41-36(46)48-22-32-19-38-24-50-32/h4-13,19,23-25,28-29,31,33,44H,14-18,20-22H2,1-3H3,(H,39,45)(H,41,46)/t28-,29-,31+,33-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 300n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151192
PNG
(US8987313, 29)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@@H](N)C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C37H47N7O4S2/c1-25(2)35-41-31(23-49-35)21-43(3)37(47)44-20-28(38)18-33(44)34(45)40-29(16-26-10-6-4-7-11-26)14-15-30(17-27-12-8-5-9-13-27)42-36(46)48-22-32-19-39-24-50-32/h4-13,19,23-25,28-30,33H,14-18,20-22,38H2,1-3H3,(H,40,45)(H,42,46)/t28-,29+,30+,33-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 310n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151201
PNG
(US8987313, 31)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)N(C)C)cs1 |r|
Show InChI InChI=1S/C39H51N7O4S2/c1-27(2)37-42-32(25-51-37)22-45(5)39(49)46-23-33(44(3)4)20-35(46)36(47)41-30(18-28-12-8-6-9-13-28)16-17-31(19-29-14-10-7-11-15-29)43-38(48)50-24-34-21-40-26-52-34/h6-15,21,25-27,30-31,33,35H,16-20,22-24H2,1-5H3,(H,41,47)(H,43,48)/t30-,31-,33+,35+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 330n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151199
PNG
(US8987313, 24)
Show SMILES CC(C)c1nc(CN(C)C(=O)NC2(CCNCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C38H49N7O4S2/c1-27(2)34-41-32(25-50-34)23-45(3)36(47)44-38(16-18-39-19-17-38)35(46)42-30(20-28-10-6-4-7-11-28)14-15-31(21-29-12-8-5-9-13-29)43-37(48)49-24-33-22-40-26-51-33/h4-13,22,25-27,30-31,39H,14-21,23-24H2,1-3H3,(H,42,46)(H,43,48)(H,44,47)/t30-,31-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 340n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151190
PNG
(US8987313, 21)
Show SMILES CC(C)c1nc(CN(C)C(=O)NC2(CCN(C)CC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
Show InChI InChI=1S/C39H51N7O4S2/c1-28(2)35-41-33(26-51-35)24-46(4)37(48)44-39(17-19-45(3)20-18-39)36(47)42-31(21-29-11-7-5-8-12-29)15-16-32(22-30-13-9-6-10-14-30)43-38(49)50-25-34-23-40-27-52-34/h5-14,23,26-28,31-32H,15-22,24-25H2,1-4H3,(H,42,47)(H,43,49)(H,44,48)/t31-,32-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 340n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151193
PNG
(US8987313, 32)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)N2CCOCC2)cs1 |r|
Show InChI InChI=1S/C41H53N7O5S2/c1-29(2)39-44-34(27-54-39)24-46(3)41(51)48-25-35(47-16-18-52-19-17-47)22-37(48)38(49)43-32(20-30-10-6-4-7-11-30)14-15-33(21-31-12-8-5-9-13-31)45-40(50)53-26-36-23-42-28-55-36/h4-13,23,27-29,32-33,35,37H,14-22,24-26H2,1-3H3,(H,43,49)(H,45,50)/t32-,33-,35+,37+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 350n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151200
PNG
(US8987313, 30)
Show SMILES CN[C@H]1C[C@H](N(C1)C(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](CC[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1 |r|
Show InChI InChI=1S/C38H49N7O4S2/c1-26(2)36-42-32(24-50-36)21-44(4)38(48)45-22-31(39-3)19-34(45)35(46)41-29(17-27-11-7-5-8-12-27)15-16-30(18-28-13-9-6-10-14-28)43-37(47)49-23-33-20-40-25-51-33/h5-14,20,24-26,29-31,34,39H,15-19,21-23H2,1-4H3,(H,41,46)(H,43,47)/t29-,30-,31+,34+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 360n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151198
PNG
(US8987313, 49)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2Cc3nc[nH]c3C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1 |r|
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 370n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))		BDBM151195
PNG
(US8987313, 36)
Show SMILES CC(C)c1nc(CN(C)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)NC(C)=O)cs1 |r|
Show InChI InChI=1S/C39H49N7O5S2/c1-26(2)37-43-33(24-52-37)21-45(4)39(50)46-22-32(41-27(3)47)19-35(46)36(48)42-30(17-28-11-7-5-8-12-28)15-16-31(18-29-13-9-6-10-14-29)44-38(49)51-23-34-20-40-25-53-34/h5-14,20,24-26,30-32,35H,15-19,21-23H2,1-4H3,(H,41,47)(H,42,48)(H,44,49)/t30-,31-,32+,35+/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 370n/an/an/an/an/a37



Gilead Sciences, Inc.

US Patent


Assay Description
The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...

US Patent US8987313 (2015)


BindingDB Entry DOI: 10.7270/Q20P0XRJ
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%